Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.
about
Heart Failure: Diagnosis, Management and UtilizationTranslational research of adult stem cell therapyEndpoints in stem cell trials in ischemic heart failureTransmyocardial revascularization devices: technology updateStem cell therapy for chronic heart failure: an updated appraisalCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsCell therapy for cardiac repair--lessons from clinical trials.Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.Bone marrow cells adopt the cardiomyogenic fate in vivo.Cell-based therapy for heart disease: a clinically oriented perspectiveEffects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Proinflammatory stem cell signaling in cardiac ischemiaIntramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.Cardiac cell therapy: where we've been, where we are, and where we should be headed.The challenges of autologous cell therapy: systemic anti-thrombotic therapies interfering with serum coagulation may disable autologous serum-containing cell products for therapeutical use.Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.Some notes on stem cell therapy in cardiovascular diseases.Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.Safety and feasibility of cell-based therapy of autologous bone marrow-derived mononuclear cells in plate-stabilized proximal humeral fractures in humans.Comparison of three different types of scaffolds preseeded with human bone marrow mononuclear cells on the bone healing in a femoral critical size defect model of the athymic rat.More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac RepairA randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarctionEffect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialStem cells in sepsis and acute lung injury.A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Exploitation of stem cell homing for gene delivery.Circulating endothelial progenitor cells inversely associate with organ dysfunction in sepsis.Aging and disease as modifiers of efficacy of cell therapy.Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.Imaging gene expression in human mesenchymal stem cells: from small to large animals.Emerging hematological targets and therapy for cardiovascular disease: From bench to bedsideEndothelial progenitor cells: markers of vascular reparative capacity.Cardiac cell repair therapy: a clinical perspective.Autologous Stem Cell Transplantation Promotes Mechanical Stretch Induced Skin Regeneration: A Randomized Phase I/II Clinical Trial.Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?
P2860
Q26745543-622E9ABD-9F75-4CA2-A67B-C91108DF1745Q26774565-2F8A948A-0B0D-4051-834C-59449B4B93E5Q26796330-331FB202-22D3-491C-B03D-13D45A22136EQ26865489-EE649C00-5411-49B3-B4E4-B3919F8B3304Q26866170-4A08A3D9-5B80-4F24-A0D8-4B7ED2B90C2CQ27001159-A7C7B2CE-6820-4AB9-A9A1-458720E8E973Q30359782-2A74C8CD-5DD1-4541-9107-7C76AD1B4D64Q30443462-952DCF45-CEFA-4C1C-A3B9-D019B5A437F3Q33304156-3BEE0263-574A-42BD-A19B-EFF6F483472CQ33713519-23628971-74F5-4FC7-B533-D37AA6D2C6CAQ33720841-85062CA3-3A9A-4E5C-B520-D093B5F3D265Q33745962-D624F799-9B64-442E-A3C6-B14BBA0289B6Q33858319-76BEA73B-5332-450A-BE5A-A9F6F4D930FAQ34066988-8763BEE4-00CC-4508-B048-9213E855E3CDQ34090699-B3966638-558F-47BF-8C72-EEC8EC6BA8CAQ34683330-CB2DE68B-EEA5-457E-96E1-5C4352C0C002Q35144550-846A339B-AC41-4714-9C9E-0F11DD2C97C3Q35250837-284331C7-BCD3-489C-8C83-FF6FDC5C25ECQ35287252-5BC203B1-8311-4B3B-B448-F4AED2CCA0EFQ35945147-D868D4EC-F7A3-4A75-B0A7-992D92371061Q36008423-EC2C4857-BAC3-4155-BE9E-F0D7892F7685Q36193483-3D940624-CB98-4B2C-9855-36EE7E34F7AEQ36382712-855EEB03-E2D8-4CC3-B9F5-A5FF6DA89F4EQ36550793-E71ABA88-09BE-4F69-BF89-C119F5C37A4DQ36634299-97060001-945B-4C42-BF7F-A92042F3A11BQ36689801-7545C6BF-0922-4AE1-86CF-DBE90E537046Q36694346-19B86586-6B3F-401C-959E-2A074969CB6DQ36916458-960E2B73-3739-4033-8FD8-54FC9AF6C884Q36944312-B022A10D-BF21-44AB-9C2C-C69EBBB92116Q37004826-568F2CF1-7A9C-4AE3-B3DE-97E482CD010DQ37032629-5B514D46-B52D-4737-87D3-A4610837A8B8Q37112017-90BAC1A9-3081-4562-A3FC-A3FCD9725C58Q37183949-E19D467F-FBF4-493B-8286-3349ED3A6994Q37194005-B5BDF1E8-F1A7-4C6B-AA50-F57832D57B58Q37242779-BAEE4749-6141-4BE7-B1B7-54EA17C73C6BQ37290687-8D3767FD-B57B-4ED8-90BB-723E6B2F5FE9Q37362743-9F66F9AC-1432-44B9-A11C-A04B6E3C91B1Q37371934-48BBBAF2-48B1-4FEE-8EA0-5DD418FFD835Q37604725-F7166AD7-B614-43BB-AD9A-B1AD41E7AAB6Q37608787-AC215128-EB0B-45B1-AA08-46355BC708EA
P2860
Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@en
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@nl
type
label
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@en
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@nl
prefLabel
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@en
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@nl
P2093
P1433
P1476
Transcoronary transplantation ...... s of the TOPCARE-CHD Registry.
@en
P2093
Erhard Seifried
Florian H Seeger
Jörg Honold
Stefanie Dimmeler
Stephan Fichtlscherer
TOPCARE-CHD Registry
Torsten Tonn
Ulrich Fischer-Rasokat
Volker Schächinger
P304
P356
10.1161/01.RES.0000264508.47717.6B
P577
2007-03-22T00:00:00Z